Regarding measures against the new coronavirus, Minister of Health, Labor and Welfare Goto has announced 1.6 million times for the domestic market on the premise that regulatory approval will be obtained with the Japanese subsidiary of the major pharmaceutical company "Merck", which develops oral medicines for mildly ill patients. Announced that it has agreed to secure medication.
Minister of Health, Labor and Welfare Goto told a reporter at the Ministry of Health, Labor and Welfare on the night of the 10th that the Japanese subsidiary of the American pharmaceutical giant "Merck" is developing "Mornupiravir", a drug for mildly ill patients that suppresses the growth of the new coronavirus. Announced that it has agreed with "MSD" to secure 1.6 million doses of medicine.
Specifically, on the premise that regulatory approval will be given in Japan, we will receive 200,000 doses for the domestic market by the end of the year, 200,000 doses each in February and March next year, and 1 million doses in addition to that. It means that it was secured.
Minister Goto said, "It has a great effect and great significance on protecting the health and life of the people. We would like to continue to take necessary measures, including domestically produced oral therapeutic agents." Said.